FDA Drug Application (021226) for KALETRA by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number021226
Product Number001
FormCAPSULE;ORAL
Dosage133.3MG;33.3MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKALETRA
Active IngredientLOPINAVIR; RITONAVIR



Back to FDA Applications sponsored by ABBVIE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.